|
|
| Research article summary (published 30 Mar 2008): |
Strategy for utilization of new antiepileptic drugs.
Full Abstract
PURPOSE OF REVIEW: The paper reviews strategies to incorporate new antiepileptic drugs into the treatment arsenal for patients with epilepsy. RECENT FINDINGS: Ten new antiepileptic drugs have been developed in the last two decades, making selection of optimal therapy complex; they have not been shown to have better efficacy but generally seem to be better tolerated. Newer antiepileptic drugs offer new opportunities to patients who have not had a favorable response to the old ones. Many new antiepileptic drugs exhibit a broad spectrum of activity while only one of the older ones (valproate) has a broad-spectrum profile. There are therefore more choices when trying to match treatment with epileptic seizures and syndromes. The side-effect profiles of the newer antiepileptic drugs differ from the older ones with fewer systemic reactions and better pharmacokinetics for the most part. SUMMARY: Comparative studies are needed to elucidate the specific weaknesses and strengths of each of the new antiepileptic drugs compared with the older ones. Most clinical trials do not help the physician in deciding drug, dose, or titration schedules. Thus the physician needs to understand efficacy spectrum and side-effect profiles of each new antiepileptic drug in order to be able to treat each patient optimally.
Author information
Author/s: Ben-Menachem, Elinor (E);
Affiliation: Institute for Clinical Neuroscience and Rehabilitation, Sahlgrenska Academy, Sahlgrenska University Hospital, Göteborg, Sweden. ebm(-atsign-)neuro.gu.se
Journal and publication information
Publication Type: Journal Article; Review
Journal: Current opinion in neurology (Curr Opin Neurol), published in England. (Language: eng)
Reference: 2008-Apr; vol 21 (issue 2) : pp 167-72
Dates: Created 2008/03/04; Completed 2008/06/13;
PMID: 18317275, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Epilepsy: a model for the study of brain function.
30 Dec 2004 - Pharmacokinetics of polypharmacy: prediction of drug interactions.
30 Dec 1995 - Developmental principles of antiepileptic drug therapy.
29 Sep 1994 - The use of monotherapy in patients with epilepsy: an appraisal of the new antiepileptic drugs.
29 Jun 2005 - Role of androgens in epilepsy.
29 Jun 2006 - The pharmacokinetics of tiagabine in healthy elderly volunteers and elderly patients with epilepsy.
30 Oct 1997 - [Epilepsy and pregnancy. Balancing between risks to the mother and child]
18 Aug 1997 - Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy.
30 Dec 1994 - [The clinical pharmacology of antiepileptic agents]
30 Aug 1990 - In vitro responsiveness of human-drug-resistant tissue to antiepileptic drugs: insights into the mechanisms of pharmacoresistance.
22 Apr 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.